Select Publications
Journal articles
2015, 'Cytoskeletal protein Flightless I inhibits apoptosis, enhances tumor cell invasion and promotes cutaneous squamous cell carcinoma progression', Oncotarget, 6, pp. 36426 - 36440, http://dx.doi.org/10.18632/oncotarget.5536
,2015, 'Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts', Journal of the American Academy of Dermatology, 72, pp. 168 - 174, http://dx.doi.org/10.1016/j.jaad.2014.08.024
,2015, 'Maternity leave: How to make it fairer for all', International Journal of Women's Dermatology, 1, pp. 57, http://dx.doi.org/10.1016/j.ijwd.2015.01.004
,2015, 'Mentorship: A key mission of the Women's Dermatologic Society', International Journal of Women's Dermatology, 1, pp. 113, http://dx.doi.org/10.1016/j.ijwd.2015.04.004
,2015, 'Outcome measures for autoimmune blistering diseases', Journal of Dermatology, 42, pp. 31 - 36, http://dx.doi.org/10.1111/1346-8138.12711
,2015, 'Pemphigus vulgaris: An evidence-based treatment update', Drugs, 75, pp. 271 - 284, http://dx.doi.org/10.1007/s40265-015-0353-6
,2015, 'Pigmented Hair-Thickening Fibers: A Camouflage Technique for Alopecia in Patients with Epidermolysis Bullosa', SKIN APPENDAGE DISORDERS, 1, pp. 153 - 155, http://dx.doi.org/10.1159/000441661
,2015, 'Prevalence of anemia in patients with epidermolysis bullosa registered in Australia', International Journal of Women's Dermatology, 1, pp. 37 - 40, http://dx.doi.org/10.1016/j.ijwd.2014.12.001
,2015, 'Recessive dystrophic epidermolysis bullosa (RDEB) complicated by secondary hepatic amyloidosis', JAAD Case Reports, 1, pp. 337 - 339, http://dx.doi.org/10.1016/j.jdcr.2015.07.006
,2015, 'Retrospective evidence on outcomes and experiences of pregnancy and childbirth in epidermolysis bullosa in Australia and New Zealand', International Journal of Women's Dermatology, 1, pp. 26 - 30, http://dx.doi.org/10.1016/j.ijwd.2014.12.005
,2015, 'Skin needling as a treatment for acne scarring: An up-to-date review of the literature', International Journal of Women's Dermatology, 1, pp. 77 - 81, http://dx.doi.org/10.1016/j.ijwd.2015.03.004
,2015, 'Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian Portuguese', International Journal of Dermatology, http://dx.doi.org/10.1111/ijd.12819
,2015, 'Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study', Australasian Journal of Dermatology, http://dx.doi.org/10.1111/ajd.12295
,2015, 'Welcome to the New International Journal of Women's Dermatology', International Journal of Women's Dermatology, 1, pp. 1, http://dx.doi.org/10.1016/j.ijwd.2014.12.008
,2015, 'Chlorophyll-induced pseudoporphyria with ongoing photosensitivity after cessation - a case series of four patients', Journal of the European Academy of Dermatology and Venereology, pp. n/a - n/a, http://dx.doi.org/10.1111/jdv.13169
,2015, 'Corrélation entre les scores de sévérité clinique (ABSIS, PDAI, PGA), la qualité de vie (DLQI) et les taux d’Ac anti-desmogléine 1 et 3 dans le suivi du pemphigus', Annales de Dermatologie et de Vénéréologie, 142, pp. S444 - S445, http://dx.doi.org/10.1016/j.annder.2015.10.048
,2015, 'Reproductibilité inter-observateur des scores de sévérité du pemphigus ABSIS et PDAI', Annales de Dermatologie et de Vénéréologie, 142, pp. S442 - S443, http://dx.doi.org/10.1016/j.annder.2015.10.047
,2014, 'Screening for infections prior to initiating immunosuppressive treatment for patients with autoimmune blistering diseases', British Journal of Dermatology, 171, pp. 1285 - 1286, http://dx.doi.org/10.1111/bjd.13451
,2014, 'Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: A randomized controlled trial', British Journal of Dermatology, 171, pp. 1164 - 1171, http://dx.doi.org/10.1111/bjd.13138
,2014, 'Diffuse melanosis cutis in the setting of BRAFV600E metastatic melanoma', International Journal of Dermatology, 53, pp. 1409 - 1411, http://dx.doi.org/10.1111/ijd.12614
,2014, 'Management of pemphigus', F1000Prime Reports, 6, http://dx.doi.org/10.12703/P6-32
,2014, 'Dental manifestations of epidermolysis bullosa', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 55, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335981400129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Oral manifestations and management of dental health in autoimmune blistering diseases', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 55, pp. 22 - 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335981400074&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Resolution of chronic multiple verruca vulgaris treated with quadrivalent human papilloma virus (HPV) vaccine', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 55, pp. 17 - 17, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335981400056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Treatment of autoimmune blistering diseases following the lymphoma protocol for rituximab: A case series of 9 patients', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 55, pp. 22 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335981400075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Type VII collagen regulates expression of OATP1B3, promotes front-to-rear polarity and increases structural organisation in 3D spheroid cultures of RDEB tumour keratinocytes', Journal of Cell Science, 127, pp. 740 - 751, http://dx.doi.org/10.1242/jcs.128454
,2014, 'Dermatology training and practice in Australia', International Journal of Dermatology, 53, pp. 1259 - 1264, http://dx.doi.org/10.1111/ijd.12728
,2014, 'Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)', Journal of the American Academy of Dermatology, 70, http://dx.doi.org/10.1016/j.jaad.2013.09.041
,2014, 'Flightless I over-expression impairs skin barrier development, function and recovery following skin blistering', Journal of Pathology, 232, pp. 541 - 552, http://dx.doi.org/10.1002/path.4323
,2014, 'From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases', Journal of Investigative Dermatology, 134, pp. 2298 - 2300, http://dx.doi.org/10.1038/jid.2014.171
,2014, 'Health-related quality of life in epidermolysis bullosa: Validation of the dutch QOLEB questionnaire and assessment in the dutch population', Acta Dermato-Venereologica, 94, pp. 442 - 447, http://dx.doi.org/10.2340/00015555-1758
,2014, 'Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification', Journal of the American Academy of Dermatology, 70, pp. 1103 - 1126, http://dx.doi.org/10.1016/j.jaad.2014.01.903
,2014, 'Report from the inaugural Australian pruritus symposium, Sydney, Australia, August 10, 2013', Acta Dermato-Venereologica, 94, pp. 123, http://dx.doi.org/10.2340/00015555-1732
,2014, 'Scoring systems for blistering diseases in practice: Why bother, and which one should you use?', JAMA Dermatology, 150, pp. 245 - 247, http://dx.doi.org/10.1001/jamadermatol.2013.8179
,2014, 'Efficacité et tolérance à long terme du vismodégib dans le carcinome baso-cellulaire avancé : analyse finale à 30 mois de l’étude pivotale ERIVANCE', Annales de Dermatologie et de Vénéréologie, 141, pp. S288 - S288, http://dx.doi.org/10.1016/j.annder.2014.09.142
,2014, 'Flightless I over-expression impairs skin barrier development, function and recovery following skin blistering', Journal of Pathology, http://dx.doi.org/10.1002/path.4323
,2014, 'Inherited epidermolysis bullosa', Journal of the Egyptian Womenʼs Dermatologic Society, 11, pp. 1 - 13, http://dx.doi.org/10.1097/01.ewx.0000437657.38804.96
,2013, 'Development of an excel® spreadsheet to document disease activity in autoimmune bullous disease', Acta Dermatovenerologica Croatica, 21, pp. 207 - 208
,2013, 'The development and validation of the Treatment of Autoimmune Bullous Disease Quality of Life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease', British Journal of Dermatology, 169, pp. 1000 - 1006, http://dx.doi.org/10.1111/bjd.12623
,2013, 'A quantitative approach to histopathological dissection of elastin-related disorders using multiphoton microscopy', British Journal of Dermatology, 169, pp. 869 - 879, http://dx.doi.org/10.1111/bjd.12430
,2013, 'Development of a quality-of-life instrument for autoimmune bullous disease: The autoimmune bullous disease quality of life questionnaire', JAMA Dermatology, 149, pp. 1186 - 1191, http://dx.doi.org/10.1001/jamadermatol.2013.4972
,2013, 'Daylight PDT: A Convenient, Similarly Effective, and Nearly Painless Alternative to Conventional PDT', JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 11, pp. 87 - 87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000323227600269&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Epidermolysis bullosa pruriginosa triggered by scabies infestation', Journal of Dermatology, 40, pp. 562 - 563, http://dx.doi.org/10.1111/1346-8138.12167
,2013, 'Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (aBCC): 18-month update of the pivotal ERIVANCE BCC study.', Journal of Clinical Oncology, 31, pp. 9037 - 9037, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.9037
,2013, 'Cross cultural adaptation of the 'Quality of Life in Epidermolysis Bullosa' (QOLEB) questionnaire: Validation and results of a Hispanic translation', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 39 - 40, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900121&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Development, reliability and validity of a novel severity score for epidermolysis bullosa: The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 47 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Epidemiology of renal impairment in the Australian epidermolysis bullosa population', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900118&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Prevalence and characterisation of anaemia in patients with epidermolysis bullosa registered in Australia', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Review of cutaneous outcomes of immunomodulatory drugs for multiple sclerosis', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 49 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900146&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Complete resolution of chronic multiple verruca vulgaris treated with quadrivalent human papillomavirus vaccine', JAMA Dermatology, 149, pp. 370 - 372, http://dx.doi.org/10.1001/jamadermatol.2013.1463
,